ISHED: 22 NOVEMBER 2012 The view from the US: Stem cell therapy steps up a gear with first approval and improved political climate Special Report Peter Winter Positive clinical data, increases in federal funding and the first regulatory approval of a manufactured stem cell product mean momentum is building